American Vietnamese Biotech (HSTC:AMV) Current Accrued Expense : ₫0.00 Mil (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Current Accrued Expense?

American Vietnamese Biotech's Current Accrued Expense for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech Current Accrued Expense Historical Data

The historical data trend for American Vietnamese Biotech's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Current Accrued Expense Chart

American Vietnamese Biotech Annual Data

Trend

Current Accrued Expense

American Vietnamese Biotech Quarterly Data

Current Accrued Expense

American Vietnamese Biotech Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

American Vietnamese Biotech Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM

Website

http://www.amvibiotech.com

American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.